Use of bergenin in preparation of drugs for treatment of diabetes
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A diabetes drug, the technology of petracenin, which is applied in the direction of drug combination, metabolic diseases, etc., can solve the problems that there is no petracenin.
Inactive Publication Date: 2012-04-04
INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
View PDF1 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
So far, there is no relevant report that petracenin has the pharmacological activity of preventing insulin resistance and improving insulin sensitivity
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
experiment example 1
[0019] 1. Main reagents and experimental animals
[0020] Petgenin was purchased from Shanghai Yansheng Biochemical Reagent Co., Ltd., with a purity of ≥98%. Glucose, TG (triglyceride) and TCHO (total cholesterol) detection kits were purchased from Beijing Zhongsheng Hi-tech Technology Company, immunohistochemical kits were purchased from Beijing Zhongshan Company, high-fat feed (containing 7.5% lard, 7.5% Safflower oil, 1% cholesterol, 1% casein, 10% sucrose, etc.) were purchased from the Experimental Animal Center of the Chinese Academy of Medical Sciences.
[0021] The animals used in the experiment were SPF grade SD rats (male, 120-140 g), which were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., animal certificate number SCXK (Beijing) 2002-0003. The animals were kept in the SPF experimental animal room of the Institute of Medicinal Botany, Chinese Academy of Medical Sciences, with constant temperature and humidity, and a high-fat diet.
...
Embodiment 1
[0036] The preparation of embodiment 1 oral liquid
[0037] Take an appropriate amount of petogenin, add an appropriate amount of solubilizer, grind, add a small amount of water to dilute, mix evenly, then add flavoring agents and preservatives, mix evenly, add water to the specified amount. Mix well, subpackage, sterilize, and get ready.
Embodiment 2
[0038] The preparation of embodiment 2 tablet
[0039]Take an appropriate amount of petogenin, add an appropriate amount of auxiliary materials, mix well, make granules, dry, and press into tablets to obtain.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention discloses a use of bergenin in preparation of drugs for treatment of diabetes, and belongs to the field of the pharmacological use of the bergenin. The results of animal experiments show that: with the bergenin, the model forming rate of type 2 diabetes rats can be significantly reduced, the occurrence and the development of insulin resistance can be prevented, the insulin resistance degree of the rats can be significantly reduced, and the insulin sensitivity of the type 2 diabetes rats can be effectively improved. In addition, the results provided by the present invention further show that: with the bergenin, the triglyceride content and the total cholesterol content in blood serum can be significantly reduced, and the lipid metabolism disorder of the type 2 diabetes rats can be effectively improved. Therefore, the results show that the bergenin can be used for preparing into the drugs for the treatment of the diabetes and the blood lipid reducing drugs.
Description
technical field [0001] The invention relates to a pharmacological use of petracenin, in particular to the use of petracenin in preparing medicines for treating diabetes, and belongs to the field of pharmacological uses of petracenin. Background technique [0002] Bergenin (bergenin), also known as Bergenin, catechin, saxifrage, Bergenin, bergamot, etc., is the whole herb of Bergenia purpurascens and thick-leaf Bergenia ( B.crassifoloa, Astilbe macroflora), Ardisia crispa and other plant roots, stems and leaves, the molecular formula is C 14 h 16 0 9 , whose structure is shown in figure 1 . [0003] Begenin has a wide range of pharmacological activities. Studies have shown that petracenin has immune enhancement, anti-inflammatory, anti-coagulant, anti-coagulant and anti-arrhythmic effects, expectorant, anti-asthma and cough-relieving effects, liver-protecting effects, anti-secretion, anti-ulcer effects, anti-HIV Virus effect and anti-oxidation effect, etc. (Xia Conglong...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61P3/10A61P3/06A61P3/00
Inventor 金文孙虹
Owner INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
Login to view more 
Login to view more